Douglas MD Reed

CIK 1291262 · last filed 2017-01-19

Douglas MD Reed is a corporate insider who has filed 9 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider sold $1.8M of CLSD on Jan 19, 2017. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. 15 SEC filings were submitted jointly with STAR EQUITY HOLDINGS, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

3

Total Filings

9

Lifetime Open-Market Net

-$1.18M

Filer Profile

Reported Address

C/O VECTOR FUND MANAGEMENT
1751 LAKE COOK ROAD, SUITE 350
DEERFIELD, IL 60015

Related Filers

STAR EQUITY HOLDINGS, INC. — 15 joint filings, latest 2008-04-24

John Crumpler — 12 joint filings, latest 2018-10-24

ROBERT ALEXANDER INGRAM — 12 joint filings, latest 2018-10-24

KENNETH B LEE JR — 12 joint filings, latest 2018-10-24

Clay Thorp — 10 joint filings, latest 2018-06-01

Hatteras Venture Advisors IV SBIC, LLC — 7 joint filings, latest 2018-06-01

Hatteras Venture Advisors III, LLC — 5 joint filings, latest 2018-10-24

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Clearside Biomedical, Inc. (CLSD) Delisted	10%+ Owner	138,691	$0.35	$48.8K	-$1.79M	1	2017-01-19
TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted	Director	142,857	—	—	$1000.0K	2	2015-01-30
STAR EQUITY HOLDINGS, INC. (DRAD) Delisted	Director	34,316	—	—	-$393.8K	6	2008-04-24

Recent Filings

9 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2017-01-19	Clearside Biomedical, Inc. (CLSD) Delisted	Sell (S)	−207,592	-$1.79M	EDGAR
2015-01-30	TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted	Grant (A)	—	$0	EDGAR
2013-12-19	TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted	Mixed	+1,209,742	$3.00M	EDGAR
2008-04-24	STAR EQUITY HOLDINGS, INC. (DRAD) Delisted	Grant (A)	—	$0	EDGAR
2008-02-14	STAR EQUITY HOLDINGS, INC. (DRAD) Delisted	Other (J)	−1,186,437	$0	EDGAR
2007-08-27	STAR EQUITY HOLDINGS, INC. (DRAD) Delisted	Sell (S)	−30,000	-$91.5K	EDGAR
2007-08-10	STAR EQUITY HOLDINGS, INC. (DRAD) Delisted	Other (J)	−801,312	$0	EDGAR
2007-05-29	STAR EQUITY HOLDINGS, INC. (DRAD) Delisted	Sell (S)	−70,000	-$302.3K	EDGAR
2007-05-08	STAR EQUITY HOLDINGS, INC. (DRAD) Delisted	Grant (A)	—	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.